Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1127754

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what his timescale is for (a) implementing and (b) completing NHS England’s planned restructuring of haemoglobinopathy services; and if he will make a statement.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256972
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>It is anticipated that NHS England’s new model for specialised haemoglobinopathy services will be in place by early 2020. The new model is designed to improve access to specialist advice and care for patients, irrespective of where they live.</p><p>As part of the new service, NHS England is establishing a National Haemoglobinopathy Panel to provide national multidisciplinary oversight. Patients with complex needs, wherever they live, will be able to be referred to the Panel for expert advice on new treatments and approaches to care. The national service specification will also include guidance for the 13 new born bloodspot screening programme laboratories to refer infants found to be positive for sickle cell disease to the 10 new specialised haemoglobinopathy teams. Whilst NHS England commissions the specialised aspect of haemoglobinopathy care, haemoglobinopathy coordinating centres will be encouraged to link with and support community-based services provided through primary care or community teams based within haemoglobinopathy teams.</p><p>The service specifications for the new specialised haemoglobinopathy teams and the haemoglobinopathy coordinating centres are due to be established in the next month and the associated impact assessment will be published as part of the suite of documents. The equality impact assessment indicates that it will advance the promotion of equality and support the reduction of health inequalities. For example, patients with thalassemia and sickle cell conditions will have equitable access to high quality specialist care and support within specialised commissioned centres irrespective of where in the country they live.</p><p>Hospital Episode Statistics data is attached, showing finished admission episodes with a primary and a primary or secondary diagnosis of sickle cell disorders by NHS England region of residence and Index of Multiple Deprivation decile in the year 2017-18.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256973 256974 257011 question first answered 04/06/2019 16:13:21 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name Data Table for Combined Diana Johnson PQs (257011) formatted.xlsx title FAE sickle cell NHS England table
	tabling member	1533 label Biography information for Dame Diana Johnson

1127755

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of NHS England’s planned restructuring of haemoglobinopathy services on (a) equitable access to services, (b) access to the most effective treatments, (c) access to highly specialised care and (d) quality of care in community-based settings for patients with sickle cell disease.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256973
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>It is anticipated that NHS England’s new model for specialised haemoglobinopathy services will be in place by early 2020. The new model is designed to improve access to specialist advice and care for patients, irrespective of where they live.</p><p>As part of the new service, NHS England is establishing a National Haemoglobinopathy Panel to provide national multidisciplinary oversight. Patients with complex needs, wherever they live, will be able to be referred to the Panel for expert advice on new treatments and approaches to care. The national service specification will also include guidance for the 13 new born bloodspot screening programme laboratories to refer infants found to be positive for sickle cell disease to the 10 new specialised haemoglobinopathy teams. Whilst NHS England commissions the specialised aspect of haemoglobinopathy care, haemoglobinopathy coordinating centres will be encouraged to link with and support community-based services provided through primary care or community teams based within haemoglobinopathy teams.</p><p>The service specifications for the new specialised haemoglobinopathy teams and the haemoglobinopathy coordinating centres are due to be established in the next month and the associated impact assessment will be published as part of the suite of documents. The equality impact assessment indicates that it will advance the promotion of equality and support the reduction of health inequalities. For example, patients with thalassemia and sickle cell conditions will have equitable access to high quality specialist care and support within specialised commissioned centres irrespective of where in the country they live.</p><p>Hospital Episode Statistics data is attached, showing finished admission episodes with a primary and a primary or secondary diagnosis of sickle cell disorders by NHS England region of residence and Index of Multiple Deprivation decile in the year 2017-18.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256972 256974 257011 question first answered 04/06/2019 16:13:21 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name Data Table for Combined Diana Johnson PQs (257011) formatted.xlsx title FAE sickle cell NHS England table
	tabling member	1533 label Biography information for Dame Diana Johnson

1127756

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish impact assessments of the potential effects of NHS England’s planned restructuring of haemoglobinopathy services on treatment of (a) all haemoglobinopathies and (b) sickle cell disease.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256974
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>It is anticipated that NHS England’s new model for specialised haemoglobinopathy services will be in place by early 2020. The new model is designed to improve access to specialist advice and care for patients, irrespective of where they live.</p><p>As part of the new service, NHS England is establishing a National Haemoglobinopathy Panel to provide national multidisciplinary oversight. Patients with complex needs, wherever they live, will be able to be referred to the Panel for expert advice on new treatments and approaches to care. The national service specification will also include guidance for the 13 new born bloodspot screening programme laboratories to refer infants found to be positive for sickle cell disease to the 10 new specialised haemoglobinopathy teams. Whilst NHS England commissions the specialised aspect of haemoglobinopathy care, haemoglobinopathy coordinating centres will be encouraged to link with and support community-based services provided through primary care or community teams based within haemoglobinopathy teams.</p><p>The service specifications for the new specialised haemoglobinopathy teams and the haemoglobinopathy coordinating centres are due to be established in the next month and the associated impact assessment will be published as part of the suite of documents. The equality impact assessment indicates that it will advance the promotion of equality and support the reduction of health inequalities. For example, patients with thalassemia and sickle cell conditions will have equitable access to high quality specialist care and support within specialised commissioned centres irrespective of where in the country they live.</p><p>Hospital Episode Statistics data is attached, showing finished admission episodes with a primary and a primary or secondary diagnosis of sickle cell disorders by NHS England region of residence and Index of Multiple Deprivation decile in the year 2017-18.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256972 256973 257011 question first answered 04/06/2019 16:13:21 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name Data Table for Combined Diana Johnson PQs (257011) formatted.xlsx title FAE sickle cell NHS England table
	tabling member	1533 label Biography information for Dame Diana Johnson

1127885

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he last made an assessment of the effectiveness of key performance indicators for NHS dental practices.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257007
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>NHS England is responsible for the commissioning of dental services and performance management of contracts held. NHS England looks at and update key dental performance indicators as a continuous improvement process. They are prepared by the NHS Business Services Agency and have a formal review annually. The indicators are shared with National Health Service dental providers to assist them in delivering a high quality service to patients. Examples of the information provided can be found on the NHS Business Services Agency website at the following link:</p><p><a href="https://www.nhsbsa.nhs.uk/dental-data" target="_blank">https://www.nhsbsa.nhs.uk/dental-data</a></p><p> </p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 04/06/2019 16:28:20 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1127888

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 September 2016 to Question 45638, on sickle cell disease screen positive babies, if he will publish the data for (a) England, (b) each Public Health England sub-region and (c) each antenatal screening provider for each year since 2009-10.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257009
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>Data on the number of sickle cell disease (SCD) babies born in England from 2010/11 are available to view here at the following link:</p><p><a href="https://www.gov.uk/government/publications/sickle-cell-and-thalassaemia-screening-data-trends-and-performance-analysis" target="_blank">https://www.gov.uk/government/publications/sickle-cell-and-thalassaemia-screening-data-trends-and-performance-analysis</a></p><p>Data prior to 2010/11 is available regionally in the National Health Service Sickle Cell and Thalassaemia Screening Programme archived reports at the following link:</p><p><a href="https://webarchive.nationalarchives.gov.uk/20150528151022/http:/sct.screening.nhs.uk/data-reports" target="_blank">https://webarchive.nationalarchives.gov.uk/20150528151022/http://sct.screening.nhs.uk/data-reports</a></p><p>From 2015/16 data is published by four regions and is reflected in the attached table.</p><p> </p><p>Data on the number of SCD babies born in England is publicly available. However, data for 2017/18 is not yet available but is due to be published at the end of 2019. Data for each antenatal screening provider is not available.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 04/06/2019 16:26:26 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name PQ257009 table formatted.docx title Number of babies with sickle cell 2009-17
	tabling member	1533 label Biography information for Dame Diana Johnson

1127890

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases: Admissions
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the latest Hospital Admitted Patient Care Activity data published in NHS Digital’s Hospital Episode Statistics data series, if he will publish the admissions data on sickle cell disorders (D57) for each (a) NHS England region and (b) Indices of Multiple Deprivation decile.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257011
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>It is anticipated that NHS England’s new model for specialised haemoglobinopathy services will be in place by early 2020. The new model is designed to improve access to specialist advice and care for patients, irrespective of where they live.</p><p>As part of the new service, NHS England is establishing a National Haemoglobinopathy Panel to provide national multidisciplinary oversight. Patients with complex needs, wherever they live, will be able to be referred to the Panel for expert advice on new treatments and approaches to care. The national service specification will also include guidance for the 13 new born bloodspot screening programme laboratories to refer infants found to be positive for sickle cell disease to the 10 new specialised haemoglobinopathy teams. Whilst NHS England commissions the specialised aspect of haemoglobinopathy care, haemoglobinopathy coordinating centres will be encouraged to link with and support community-based services provided through primary care or community teams based within haemoglobinopathy teams.</p><p>The service specifications for the new specialised haemoglobinopathy teams and the haemoglobinopathy coordinating centres are due to be established in the next month and the associated impact assessment will be published as part of the suite of documents. The equality impact assessment indicates that it will advance the promotion of equality and support the reduction of health inequalities. For example, patients with thalassemia and sickle cell conditions will have equitable access to high quality specialist care and support within specialised commissioned centres irrespective of where in the country they live.</p><p>Hospital Episode Statistics data is attached, showing finished admission episodes with a primary and a primary or secondary diagnosis of sickle cell disorders by NHS England region of residence and Index of Multiple Deprivation decile in the year 2017-18.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256972 256973 256974 question first answered 04/06/2019 16:13:21 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name Data Table for Combined Diana Johnson PQs (257011) formatted.xlsx title FAE sickle cell NHS England table
	tabling member	1533 label Biography information for Dame Diana Johnson

1127963

	registered interest
	date	21/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department measures public satisfaction with NHS dental care.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	257031
	answer	answer is ministerial correction date of answer 04/06/2019 answer text <p>The Department measures public satisfaction of National Health Service dental services through National Health Service Outcomes Framework. The NHS Outcomes Framework is also used to monitor the health outcomes of adults and children in England. For NHS dentistry this is captured through 4.4.iii Access to NHS dental services. The indicator uses data collected in the GP Patient Survey to ask whether patients were successful in getting an NHS dental appointment if they tried in the last two years.</p><p>Latest data shows that of the respondents that tried to get NHS dental care in the last two years, 85.2% of respondents rated their NHS dental experience as positive.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 04/06/2019 16:29:14 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1127698

	registered interest
	date	20/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 April 2018 to Question 135010 on Sickle Cell Diseases, if he will provide updated estimates of the costs to the NHS of treating sickle cell anaemia in (a) England (b) each NHS England region and (c) each Clinical Commissioning Group area in each year since 2009-10.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256313
	answer	answer is ministerial correction date of answer 23/05/2019 answer text <p>NHS England specialised commissioning only reports the costs of the National Health Service specialised commissioning services by region and hub for treating sickle cell disease, which includes sickle cell anaemia. This information is shown in the following table. The data is not broken down by clinical commissioning group (CCG) area. This information does not include non-specialised activity that CCGs may fund. Information was not collected prior to 2015/16 and information for 2018/19 is not currently available.</p><p> </p><p>Costs of NHS specialised commissioning services by region and hub for treating sickle cell disease</p><table><tbody><tr><td><p>Region</p></td><td><p>Hub</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>£ million</p></td><td><p>£ million</p></td><td><p>£ million</p></td></tr><tr><td><p>London</p></td><td><p> </p></td><td><p>29.9</p></td><td><p>31.0</p></td><td><p>44.8</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Midlands and East</p></td><td><p>East of England</p></td><td><p>1.6</p></td><td><p>1.7</p></td><td><p>3.3</p></td></tr><tr><td><p> </p></td><td><p>East Midlands</p></td><td><p>0.8</p></td><td><p>0.8</p></td><td><p>1.4</p></td></tr><tr><td><p> </p></td><td><p>West Midlands</p></td><td><p>2.7</p></td><td><p>2.5</p></td><td><p>3.2</p></td></tr><tr><td><p>Midlands and East Total</p></td><td><p> </p></td><td><p>5.1</p></td><td><p>5.0</p></td><td><p>7.9</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>North</p></td><td><p>North East</p></td><td><p>0.1</p></td><td><p>0.2</p></td><td><p>0.2</p></td></tr><tr><td><p> </p></td><td><p>North West</p></td><td><p>2.8</p></td><td><p>2.3</p></td><td><p>2.3</p></td></tr><tr><td><p> </p></td><td><p>Yorkshire &amp; Humber</p></td><td><p>1.1</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>North Total</p></td><td><p> </p></td><td><p>4.0</p></td><td><p>3.0</p></td><td><p>3.4</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>South</p></td><td><p>South East</p></td><td><p>1.8</p></td><td><p>1.9</p></td><td><p>2.6</p></td></tr><tr><td><p> </p></td><td><p>South West</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.7</p></td></tr><tr><td><p> </p></td><td><p>Wessex</p></td><td><p>0.5</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>South Total</p></td><td><p> </p></td><td><p>2.5</p></td><td><p>2.5</p></td><td><p>4.2</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>41.6</p></td><td><p>41.5</p></td><td><p>60.4</p></td></tr></tbody></table><p> </p><p>Source: Costs extracted from the annual CCG exercise.</p><p>Between 2012/13 and 2018/19, approximately 117,000 patients were admitted to hospital with a primary diagnosis of sickle cell disease. Information for years prior to 2012/13 is not available. NHS England has advised that it is unable to separate expenditure between admitted patient care episodes and the overall costs provided in the table without incurring disproportionate cost.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256314 question first answered 23/05/2019 14:40:15 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1127699

	registered interest
	date	20/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sickle Cell Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 8 December 2014 to Question 216527 on Sickle Cell Diseases, if he will provide updated estimates of the costs to NHS of admitted patient care episodes for sickle cell anaemia in (a) England, (b) each NHS England region and (c) each Clinical Commissioning Group area in each year since 2009-10.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	256314
	answer	answer is ministerial correction date of answer 23/05/2019 answer text <p>NHS England specialised commissioning only reports the costs of the National Health Service specialised commissioning services by region and hub for treating sickle cell disease, which includes sickle cell anaemia. This information is shown in the following table. The data is not broken down by clinical commissioning group (CCG) area. This information does not include non-specialised activity that CCGs may fund. Information was not collected prior to 2015/16 and information for 2018/19 is not currently available.</p><p> </p><p>Costs of NHS specialised commissioning services by region and hub for treating sickle cell disease</p><table><tbody><tr><td><p>Region</p></td><td><p>Hub</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>£ million</p></td><td><p>£ million</p></td><td><p>£ million</p></td></tr><tr><td><p>London</p></td><td><p> </p></td><td><p>29.9</p></td><td><p>31.0</p></td><td><p>44.8</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Midlands and East</p></td><td><p>East of England</p></td><td><p>1.6</p></td><td><p>1.7</p></td><td><p>3.3</p></td></tr><tr><td><p> </p></td><td><p>East Midlands</p></td><td><p>0.8</p></td><td><p>0.8</p></td><td><p>1.4</p></td></tr><tr><td><p> </p></td><td><p>West Midlands</p></td><td><p>2.7</p></td><td><p>2.5</p></td><td><p>3.2</p></td></tr><tr><td><p>Midlands and East Total</p></td><td><p> </p></td><td><p>5.1</p></td><td><p>5.0</p></td><td><p>7.9</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>North</p></td><td><p>North East</p></td><td><p>0.1</p></td><td><p>0.2</p></td><td><p>0.2</p></td></tr><tr><td><p> </p></td><td><p>North West</p></td><td><p>2.8</p></td><td><p>2.3</p></td><td><p>2.3</p></td></tr><tr><td><p> </p></td><td><p>Yorkshire &amp; Humber</p></td><td><p>1.1</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>North Total</p></td><td><p> </p></td><td><p>4.0</p></td><td><p>3.0</p></td><td><p>3.4</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>South</p></td><td><p>South East</p></td><td><p>1.8</p></td><td><p>1.9</p></td><td><p>2.6</p></td></tr><tr><td><p> </p></td><td><p>South West</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.7</p></td></tr><tr><td><p> </p></td><td><p>Wessex</p></td><td><p>0.5</p></td><td><p>0.5</p></td><td><p>0.9</p></td></tr><tr><td><p>South Total</p></td><td><p> </p></td><td><p>2.5</p></td><td><p>2.5</p></td><td><p>4.2</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>41.6</p></td><td><p>41.5</p></td><td><p>60.4</p></td></tr></tbody></table><p> </p><p>Source: Costs extracted from the annual CCG exercise.</p><p>Between 2012/13 and 2018/19, approximately 117,000 patients were admitted to hospital with a primary diagnosis of sickle cell disease. Information for years prior to 2012/13 is not available. NHS England has advised that it is unable to separate expenditure between admitted patient care episodes and the overall costs provided in the table without incurring disproportionate cost.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 256313 question first answered 23/05/2019 14:40:15 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1533 label Biography information for Dame Diana Johnson

1127174

	registered interest
	date	16/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many NHS-registered dental practitioners have ceased to provide NHS services in each of the last 10 years.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	255310
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The NHS Business Services Authority collects data on the number of dentists (performers) who provide some National Health Service primary care dental services in each financial year. This data includes information on leavers and joiners. Leavers are defined as dentists who performed NHS activity in one year but then recorded no activity in the following year and Joiners are defined dentists who recorded NHS activity in the later year but who did not record NHS activity in the previous year. The information requested on NHS-registered dental practitioners ceasing to provide NHS services for the last 10 years is attached. Most dentists (associates) work on NHS contracts held by other dentists with NHS England.</p><p>No information is held on the reasons for an individual dentist leaving an NHS contract. Where the dentist is a contract holder the funding returns to NHS England and it is able to re-let the contract. Where the dentist is working on a contract as an associate the contract holder will seek to recruit a replacement dentist. Overall in the last year for which data is available, 2017/18 total numbers of dentists providing some NHS service increased.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 255312 question first answered 21/05/2019 16:10:13 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name PQ255310 table formatted.xlsx title NHS Dentists Ceasing NHS Services 2007-2018
	tabling member	1533 label Biography information for Dame Diana Johnson